New continuing education choices for sales reps
The Certified Medical Representatives Institute Inc., Roanoke, VA, has added three new self-study courses to its continuing education program for pharmaceutical sales representatives.
The Certified Medical Representatives Institute Inc., Roanoke, VA, has added three new self-study courses to its continuing education program for pharmaceutical sales representatives.
"Diabetes: Approaches in Disease Management" addresses the clinical and economic impact of diabetes management, profiles current treatment guidelines and describes the different diabetes management programs being developed by pharmaceutical companies.
"Contemporary Pharmacoeconomics" describes pharmacoeconomic research methods and their applications in health care. It encompasses the relationship between disease management, outcomes management, pharmacoeconomics and quality-of-life surveys, as well as the role of pharmacoeconomics in formulary decision-making.
"Outcomes Measurement, Management and Marketing" presents an overview of outcomes research and management in the health care delivery process and how outcomes data can be used as a valuable selling tool. It also explains how and why some pharmaceutical companies are partnering with managed care organizations to conduct outcomes research.
The courses are self-directed and approved for credit toward CMR certification. Representatives who wish to be certified by CMR may concentrate in one of three areas of study: business in health care, disease management or science and medicine.
For more information, call (800) 274-2674. PR
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
